Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats

Psychopharmacology

Volumn 191, Issue 4, 2007, Pages 857-865

  Saitoh, Akiyoshi ^a   Yamaguchi, Kazumasa ^b   Tatsumi, Yoshimi ^c   Murasawa, Hiroyasu ^b   Nakatani, Akiko ^b   Hirose, Noritaka ^a   Yamada, Misa ^d   Yamada, Mitsuhiko ^d   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

^b Nihon Bioresearch Inc   (Japan)

^c Narabyouri Research Co Ltd   (Japan)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Fluvoxamine; Milnacipran; Olfactory bulbectomy; Tryptophan hydroxylase

Indexed keywords

ENZYME ANTIBODY; FLUVOXAMINE; FLUVOXAMINE MALEATE; MILNACIPRAN; SEROTONIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG EFFECT; DRUG EFFICACY; EMOTIONAL DISORDER; LONG TERM CARE; MALE; MAZE TEST; NONHUMAN; OLFACTORY BULBECTOMY; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; RATING SCALE; SEROTONINERGIC NERVE CELL; TREATMENT DURATION; TREATMENT OUTCOME;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BEHAVIOR, ANIMAL; CYCLOPROPANES; DOSE-RESPONSE RELATIONSHIP, DRUG; EMOTIONS; FLUVOXAMINE; MALE; MOTOR ACTIVITY; NEURONS; OLFACTORY BULB; RAPHE NUCLEI; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; TRYPTOPHAN HYDROXYLASE;

EID: 33947107943     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0699-x     Document Type: Article

References (34)

1. Blier P, de Montigny C, Chaput Y (1990) A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry 51(Suppl):14-20
2. Bohmaker K, Bordi F, Meller E (1992) The effects of pertussis toxin on dopamine D2 and serotonin 5-HT1A autoreceptor-mediated inhibition of neurotransmitter synthesis: relationship to receptor reserve. Neuropharmacology 31:451-459
3. Brady JV, Nauta WJ (1955) Subcortical mechanisms in emotional behavior: the duration of affective changes following septal and habenular lesions in the albino rat. J Comp Physiol Psychol 48:412-420
4. Chaki S, Nakazato A, Kennis L, Nakamura M, Mackie C, Sugiura M, Vinken P, Ashton D, Langlois X, Steckler T (2004) Anxiolytic-and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450. Eur J Pharmacol 485:145-158
5. Esteban S, Llado J, Sastre-Coll A, Garcia-Sevilla JA (1999) Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo. Naunyn Schmiedebergs Arch Pharmacol 360:135-143
6. Fukuchi T, Kanemoto K (2000) Differential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: a case-control study. Int Clin Psychopharmacol 17:53-58
7. Gartside SE, Cowen PJ, Sharp T (1992) Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology 31:9-14
8. Grecksch G, Zhou D, Franke C, Schroder U, Sabel B, Becker A, Huether G (1997) Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates. Br J Pharmacol 122:1725-1731
9. Hasegawa S, Watanabe A, Nguyen KQ, Debonnel G, Diksic M (2005) Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study. Psychopharmacology (Berl) 179:781-790
10. Ho Y, Liu T, Tai M, Wen Z, Chow RS, Tsai Y, Wong C (2001) Effects of olfactory bulbectomy on NMDA receptor density in the rat brain. Brain Res 900:214-218
11. Ho YJ, Chen KH, Tai MY, Tsai YF (2004) MK-801 suppresses muricidal behavior but not locomotion in olfactory bulbectomized rats: involvement of NMDA receptors. Pharmacol Biochem Behav 77:641-646
12. Kelly JP, Leonard BE (1994) The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology 33:1011-1116
13. Kelly JP, Wrynn AS, Leonard BE (1997) The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 74:299-316
14. Lumia AR, Teicher MH, Salchli F, Ayers E, Possidente B (1992) Olfactory bulbectomy as a model for agitated hyposerotonergic depression. Brain Res 1587:181-185
15. McGrath C, Norman TR (1998) The effect of venlafaxine treatment on the behavioural and neurochemical changes in the olfactory bulbectomised rat. Psychopharmacology 136:394-401
16. Meoni P, Salinas E, Brault Y, Hackett D (2001) Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder. J Clin Psychiatry 62:888-893
17. Mochizuki D, Tsujita R, Yamada S, Kawasaki K, Otsuka Y, Hashimoto S, Hattori T, Kitamura Y, Miki N (2002) Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats. Psychopharmacology 162:323-332
18. 1a agonist buspirone on serotonin synthesis in the rat brain. J Neurochem 72:2022-2031
19. Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Nakazato A, Kumagai T, Okubo T, Tomisawa K (1999) Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. J Pharmacol Exp Ther 289:926-935
20. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-167
21. Redmond AM, Kelly JP, Leonard BE (1997) Behavioural and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression. Pharmacol Biochem Behav 58:355-359
22. Redmond AM, Kelly JP, Leonard B (1999) The determination of the optimal dose of milnacipran in the olfactory bulbectomized rat model of depression. Pharmacol Biochem Behav 62:619-623
23. Saitoh A, Yamaguchi K, Murasawa H, Kamei J (2003) The approaches in the discovery of antidepressants using affective disorder models. Japanese Journal of Neuropsychopharmacology 23:75-82
24. Saitoh A, Hirose N, Yamada M, Yamada M, Nozaki C, Oka T, Kamei J (2006) Changes in emotional behavior of mice in the hole-board test after olfactory bulbectomy. J Pharmacol Sci 102:377-386
25. Shibata S, Nakanishi H, Watanabe S, Ueki S (1984) Effects of chronic administration of antidepressants on mouse-killing behavior (muricide) in olfactory bulbectomized rats. Pharmacol Biochem Behav 21:225-230
26. Song C, Leonard BE (1997) Changes in behavior, neurotransmitters and neutrophil function in olfactory bulbectomized rats: Effects of chronic desipramine treatment. Hum Psychopharmacol 12:99-103
27. Song C, Leonard BE (2005) The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29:627-647
28. Stahl SM, Grady MM, Moret C, Briley M (2006) SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 10:732-747
29. Thorne BM, Rowles JS (1988) Memory deficit in passive-avoidance learning in bulbectomized Long-Evans hooded rats. Physiol Behav 44:339-345
30. van der Stelt HM, Breuer ME, Olivier B, Westenberg HG (2005) Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study. Biol Psychiatry 57:1061-1067
31. van Riezen H, Leonard BE (1990) Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats. Pharmacol Ther 47:21-34
32. Watanabe A, Tohyama Y, Nguyen KQ, Hasegawa S, Debonnel G, Diksic M (2003) Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: an autoradiographic study. J Neurochem 85:469-475
33. Wieronska JM, Papp M, Pilc A (2001) Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats. Pol J Pharmacol 53:517-525
34. Yamaguchi K, Murasawa H, Kyuki K (2002) Animal models to elucidate depression and anxiety: usability of hyperemotionality and time on closed-arms of an elevated plus-maze (+maze) in olfactory bulbectomized (OB) rats. Jpn J Pharmacol 88:235